EB306 – NASAL DECONGESTANT SPRAY
USA FDA NDC 53304-0306; Marketing Start Date: 2012-11-01
Purpose: Nasal Decongestant
Warnings: For external use only
Directions:
Adults and children 2 to under 6 years of age:
2 to 3 drops or spray (1 cc) onto two sides of nose and the philtrum area, then rub dry.
Children under 2 years of age: Consult a doctor.
Distinguishing features of this product:
■ Active ingredient (Phenylephrine Hydrochloride) is approved by USA FDA as effective ingredient. Together with other inactive ingredients after processing to have the maximum combined effect.
■ External use, apply onto two sides of nose and philtrum area
■ Immediately soothing the symptom.
■ Unique product in the world
■ Processing by cutting-edge technology
■ Thru all the production processes, there is neither emission nor exhaust of hazardous wastes with any state of gaseous, liquid and solid.
Performance Record
Applied for allergic rhinitis and nasosinusitis, please refer to the PDF file EB306 - Allergic Rhinitis and Nasosinusitis
USA FDA: U.S. Food and Drug Administration
NDC: National Drug Code (U.S.)
According to USA FDA’s regulation, the product can be made and marketed from the listed date.